tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

DSGN Stock Latest News

Design Therapeutics management to meet with Piper Sandler
The FlyDesign Therapeutics management to meet with Piper Sandler
4d ago
DSGN
Design Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Design Therapeutics management to meet with Piper Sandler
10d ago
DSGN
Design Therapeutics, Inc.: Navigating Liquidity Risks Amidst Bank Failures
PremiumCompany Announcements
Design Therapeutics, Inc.: Navigating Liquidity Risks Amidst Bank Failures
1M ago
DSGN
Design Therapeutics reports Q4 EPS (21c), consensus (31c)
PremiumThe Fly
Design Therapeutics reports Q4 EPS (21c), consensus (31c)
1M ago
DSGN
Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results
1M ago
DSGN
Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update
PremiumPress ReleasesDesign Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update
2M ago
DSGN
Design Therapeutics, Inc. (DSGN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Design Therapeutics, Inc. (DSGN) Q4 Earnings Cheat Sheet
2M ago
DSGN
Design Therapeutics cut to Neutral at Piper on limited near-term news flow
PremiumThe Fly
Design Therapeutics cut to Neutral at Piper on limited near-term news flow
5M ago
DSGN
Design Therapeutics downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
Design Therapeutics downgraded to Neutral from Overweight at Piper Sandler
5M ago
DSGN
Design Therapeutics price target lowered to $4 from $7 at RBC Capital
PremiumThe Fly
Design Therapeutics price target lowered to $4 from $7 at RBC Capital
5M ago
DSGN
Design Therapeutics reports Q3 EPS (28c), consensus (41c)
PremiumThe Fly
Design Therapeutics reports Q3 EPS (28c), consensus (41c)
5M ago
DSGN
Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024
PremiumPress Releases
Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024
5M ago
DSGN
Multiple Downgrades Send Design Therapeutics (NASDAQ:DSGN) Down in Flames
PremiumMarket NewsMultiple Downgrades Send Design Therapeutics (NASDAQ:DSGN) Down in Flames
8M ago
DSGN
Redfin upgraded, CSSE downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Redfin upgraded, CSSE downgraded: Wall Street’s top analyst calls
9M ago
HXL
ODD
Design Therapeutics downgraded to Market Perform at SVB Securities
PremiumThe Fly
Design Therapeutics downgraded to Market Perform at SVB Securities
9M ago
DSGN
Wedbush downgrades Design Therapeutics to Neutral, cuts price target to $6
PremiumThe Fly
Wedbush downgrades Design Therapeutics to Neutral, cuts price target to $6
9M ago
DSGN
RBC cuts Design Therapeutics to Sector Perform, sees DT-216 data fall short
PremiumThe Fly
RBC cuts Design Therapeutics to Sector Perform, sees DT-216 data fall short
9M ago
DSGN
Design Therapeutics downgraded to Neutral from Outperform at Wedbush
PremiumThe Fly
Design Therapeutics downgraded to Neutral from Outperform at Wedbush
9M ago
DSGN
Design Therapeutics downgraded to Market Perform from Outperform at SVB Securities
PremiumThe Fly
Design Therapeutics downgraded to Market Perform from Outperform at SVB Securities
9M ago
DSGN
Design Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
PremiumThe FlyDesign Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
9M ago
DSGN
Design: Variability of results limited utility of FXN protein measurement
PremiumThe Fly
Design: Variability of results limited utility of FXN protein measurement
9M ago
DSGN
Design Therapeutics reports Q2 EPS (36c), consensus (40C)
PremiumThe Fly
Design Therapeutics reports Q2 EPS (36c), consensus (40C)
9M ago
DSGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >